Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Antiviral Drugs Market Size By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Herpes Simplex Virus [HSV], Coronavirus Infection), By Type (Branded, Generic), By Age Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The antiviral drugs market is slated to witness notable expansion through ... Read More
-
Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, DPT, Yellow Fever, Typhoid, Japanese Encephalitis, Measles Mumps & Rubella, Rabies, Polio, Influenza, Varicella & Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel)
... Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel) The travel vaccines market is projected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow ... Read More
-
2022-2026 Hepatitis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, ... Read More
-
2022 Global: Hepatitis Test Solution/Diagnosis - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022-2026 Succeeding in the France Hepatitis Diagnostic Market for 10 Markers: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV ... Read More
-
2022-2026 Succeeding in the UK Hepatitis Diagnostic Market for 10 Markers: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, ... Read More
-
2022-2026 Succeeding in the US Hepatitis Diagnostic Market for 10 Markers: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, ... Read More
-
2022-2026 Succeeding in the Europe Hepatitis Diagnostic Market for 10 Markers: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and ... Read More
-
2022-2026 Succeeding in the Global Hepatitis Diagnostic Market for 10 Markers: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test ... Read More
-
2022-2026 Succeeding in the Germany Hepatitis Diagnostic Market for 10 Markers: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV ... Read More
-
2022-2026 Succeeding in the Italy Hepatitis Diagnostic Market for 10 Markers: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV ... Read More
-
Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) - Global Forecast to 2027
... global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) ... Read More
-
Global H1N1 (swine flu) Vaccination Market Size study, By Treatment Type (Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella), By Route of Administration (Hospitals, Clinics, Research and Diagnostic Laboratories, Others), By End User (Hospitals, Clinics, Research and Diagnostic Laboratories, Others), and Regional Forecasts 2022-2028
... Clinics, Research and Diagnostic Laboratories, Others), and Regional Forecasts 2022-2028Global H1N1 (swine flu) Vaccination Market is valued approximately USD 1.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Hepatitis A Vaccine Market Insights, Forecast to 2028
... worth US$ 735.86 million in 2022 and is forecast to a readjusted size of US$ 840.42 million by 2028 with a CAGR of 2.24% during the review period. The global key manufacturers of Hepatitis A ... Read More
-
Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer, Troponin I}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global blood plasma derivatives market was valued at ... Read More
-
Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)
... to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028. Travelling and tourism have become an integral part ... Read More
-
Global Hepatitis C treatment Market - 2021-2028
... a CAGR of XX % during the forecast period (2021-2028). Infection with the hepatitis C virus (HCV) produces inflammation in the liver, leading to various issues, including cancer. HCV medications either permanently remove (or clear) ... Read More
-
2022 Global Forecast for Hepatitis Test Solution/Diagnosis (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulin, and Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - ... Read More
-
Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, ... Read More
-
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
... point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors ... Read More
-
Global Hepatitis B Vaccine Market - 2021-2028
... at a CAGR of XX % during the forecast period (2021-2028). The hepatitis B vaccine is a vaccine that protects against hepatitis B. The first dose should be given within 24 hours of birth, followed ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
Research Assistance
